{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:57:07Z","timestamp":1781909827282,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.biopha.2018.12.076","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:51:58Z","timestamp":1545612718000},"page":"270-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Are the Statins promising antifungal agents against invasive candidiasis?"],"prefix":"10.1016","volume":"111","author":[{"given":"William Gustavo","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia Anita","family":"Alves-Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Tauany","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7374-4743","authenticated-orcid":false,"given":"Rosy Iara Maciel","family":"de Azambuja Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph Gruppi","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Batista","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline Maria Siqueira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Cristina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.12.076_bib0005","series-title":"Candidiasis","author":"Centers for Disease Control and Prevention (CDC)","year":"2017"},{"key":"10.1016\/j.biopha.2018.12.076_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pop.2015.08.004","article-title":"Superficial fungal infections","volume":"42","author":"Kaushik","year":"2015","journal-title":"Prim. Care"},{"key":"10.1016\/j.biopha.2018.12.076_bib0015","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biopha.2018.12.076_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.riam.2016.02.003","article-title":"EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay","volume":"33","author":"Maseda","year":"2016","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.23736\/S0375-9393.17.11528-2","article-title":"Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICU","volume":"83","author":"Dimopoulos","year":"2017","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s15010-009-8249-6","article-title":"The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis","volume":"37","author":"de Ruiter","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.biopha.2018.12.076_bib0035","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.12.076_bib0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.riam.2016.12.001","article-title":"J\u00e1vea consensus guidelines for the treatment of Candida peritonitis and other intra-abdominal fungal infections in non-neutropenic critically ill adult patients","volume":"34","author":"Pem\u00e1n","year":"2017","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.biopha.2018.12.076_bib0050","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.biopha.2018.12.076_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-abdominal candidiasis: the importance of early source control and antifungal treatment","volume":"11","author":"Vergidis","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.12.076_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.12.076_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","article-title":"Antifungal drug resistance: evolution, mechanisms and impact","volume":"45","author":"Revie","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America","volume":"42","author":"Talbot","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.12.076_bib0075","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2217\/fmb.09.97","article-title":"Antibiotics: derivative drugs, novel compounds and the need for effective resistance strategies","volume":"4","author":"Theuretzbacher","year":"2009","journal-title":"Future Microbiol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/AAC.01087-13","article-title":"Antifungal application of nonantifungal drugs","volume":"58","author":"Stylianou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.12.076_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2018.00218","article-title":"Drug repositioning in glioblastoma: a pathway perspective","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.117.242081","article-title":"Pleiotropic and adverse effects of statins-do epigenetics play a role?","volume":"362","author":"Allen","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.12.076_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024394","article-title":"Studies on the antibacterial effects of statins in vitro and in vivo","volume":"6","author":"Bergman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.12.076_bib0100","doi-asserted-by":"crossref","first-page":"16407","DOI":"10.1038\/srep16407","article-title":"Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent","volume":"5","author":"Thangamani","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.12.076_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1475-2875-13-189","article-title":"In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum","volume":"25","author":"Dormoi","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2018.12.076_bib0110","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s00436-015-4618-5","article-title":"Antileishmanial effect of mevastatin is due to interference with sterol metabolism","volume":"114","author":"Dinesh","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2018.12.076_bib0115","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/JVI.02277-15","article-title":"Type I interferon counteracts antiviral effects of statins in the context of Gammaherpesvirus infection","volume":"90","author":"Lange","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0120","doi-asserted-by":"crossref","first-page":"e00660","DOI":"10.1128\/mBio.00660-18","article-title":"Statins suppress ebola virus infectivity by interfering with glycoprotein processing","volume":"9","author":"Shrivastava-Ranjan","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.biopha.2018.12.076_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biopha.2018.12.076_bib0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","article-title":"Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species","volume":"19","author":"Brilhante","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.12.076_bib0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41429-018-0048-9","article-title":"Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents","volume":"71","author":"Andrade","year":"2018","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biopha.2018.12.076_bib0140","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility - Testing of Yeasts (Document M27-A3)","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.biopha.2018.12.076_bib0145","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard (Document M07-A9)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.biopha.2018.12.076_bib0150","first-page":"1","volume":"9","author":"Gon\u00e7alves","year":"2018"},{"key":"10.1016\/j.biopha.2018.12.076_bib0155","series-title":"Biological Evaluation of Medical Devices \u2014 Part 5: Tests for in Vitro Cytotoxicity","author":"International standart (ISO) 10993-5","year":"2009"},{"key":"10.1016\/j.biopha.2018.12.076_bib0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","article-title":"A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity","volume":"56","author":"Twentyman","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2018.12.076_bib0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/jpnr.JPNR_11_17","article-title":"Absence of antibacterial, anti-Candida, and anti-dengue activities of a surfactin isolated from Bacillus subtilis","volume":"9","author":"Lima","year":"2018","journal-title":"J. Pharm. Negative Results"},{"key":"10.1016\/j.biopha.2018.12.076_bib0170","first-page":"1","article-title":"Growing and Analyzing Static Biofilms","author":"Merritt","year":"2005","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.sajb.2017.11.010","article-title":"Antibacterial and antifungal activities of phenolic compound-enriched ethyl acetate fraction from Cochlospermum regium (mart. Et. Schr.) Pilger roots: mechanisms of action and synergism with tannin and gallic acid","volume":"114","author":"Carvalho","year":"2018","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.biopha.2018.12.076_bib0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s40064-016-2130-8","article-title":"Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis","volume":"5","author":"do Couto","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.biopha.2018.12.076_bib0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s40064-015-1645-8","article-title":"Antibacterial activity of nineteen selected natural products against multi-drug resistant gram-negative phenotypes","volume":"4","author":"Mbaveng","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.biopha.2018.12.076_bib0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652012000400003","article-title":"In vitro synergism of simvastatin and fluconazole against candida species","volume":"54","author":"Menezes","year":"2012","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.biopha.2018.12.076_bib0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/13693786.2011.610037","article-title":"Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis","volume":"50","author":"Tashiro","year":"2012","journal-title":"Med. Mycol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/439243","article-title":"Synthesis and antimicrobial screening of novel 4-Substituted Phenyl-5-[1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl]-2H-1,2,4-triazole-3-thiones","author":"Bhandari","year":"2014","journal-title":"Int. Sch. Res. Notices 2014"},{"key":"10.1016\/j.biopha.2018.12.076_bib0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1248\/cpb.57.685","article-title":"Synthesis, nematicidal and antimicrobial properties of Bis-[4-methoxy-3-[3-(4-fluorophenyl)-6-(4-methylphenyl)-2(aryl)-tetrahydro-2H-pyrazolo[3,4-d]thiazol-5-yl]phenyl]methanes","volume":"57","author":"Sanjeeva Reddy","year":"2009","journal-title":"Chem. Pharm. Bull (Tokyo)"},{"key":"10.1016\/j.biopha.2018.12.076_bib0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-827X(01)01143-0","article-title":"Synthesis and antimicrobial activity of some novel 2-(p-substituted-phenyl)-5-substituted-carbonylaminobenzoxazoles","volume":"57","author":"Arpaci","year":"2002","journal-title":"Farmaco"},{"key":"10.1016\/j.biopha.2018.12.076_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jvim.14875","article-title":"The gastrointestinal microbiome: a review","volume":"32","author":"Barko","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.biopha.2018.12.076_bib0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","article-title":"Intestinal Lactobacillus in health and disease, a driver or just along for the ride?","volume":"49","author":"Heeney","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0225","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jcrc.2010.08.005","article-title":"The value of amphotericin B in the treatment of invasive fungal infections","volume":"26","author":"Klepser","year":"2011","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.biopha.2018.12.076_bib0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","article-title":"Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification","volume":"30","author":"Cabral","year":"2013","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.biopha.2018.12.076_bib0240","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.172.5.2903","article-title":"A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma","volume":"172","author":"McKay","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.12.076_bib0245","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1590\/S0074-02762012000400012","article-title":"Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease","volume":"107","author":"Silva","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2018.12.076_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073706","article-title":"Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.12.076_bib0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI39843","article-title":"Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease","volume":"120","author":"Rosch","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.12.076_bib0260","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri3897","article-title":"Immune defence against Candida fungal infections","volume":"15","author":"Netea","year":"2015","journal-title":"Nat. Rev. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218346602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218346602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:31:40Z","timestamp":1760095900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218346602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"alternative-id":["S0753332218346602"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.076","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are the Statins promising antifungal agents against invasive candidiasis?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}